Login

Novo Holdings A/S 3 SEC Filings

Filed On Filing
30 Apr 2026 Form 3: Novo Holdings A/S, 10% owner · Hemab Therapeutics Holdings Inc
29 Apr 2026 Form 3: Novo Holdings A/S, 10% owner · Avalyn Pharma Inc
27 Oct 2025 Form 3: Novo Holdings A/S, 10% owner · MapLight Therapeutics, Inc.
08 Feb 2024 Form 3: Novo Holdings A/S, 10% owner · Metagenomi Therapeutics Inc
03 Jan 2023 Form 3: Novo Holdings A/S, 10% owner · Disc Medicine, Inc.

Holds 2,340,772 shares of COMMON STOCK

03 Feb 2022 Form 3: Novo Holdings A/S, 10% owner · Arcellx, Inc.
04 Nov 2021 Form 3: Novo Holdings A/S, 10% owner · IO Biotech, Inc.
21 Oct 2021 Form 3: Novo Holdings A/S, 10% owner · MINERVA SURGICAL INC
17 Jun 2021 Form 3: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
16 Jun 2021 Form 3: Novo Holdings A/S, 10% owner · Verve Therapeutics, Inc.
08 Apr 2021 Form 3: Novo Holdings A/S, 10% owner · Onkure Therapeutics Inc
25 Mar 2021 Form 3: Novo Holdings A/S, 10% owner · Edgewise Therapeutics, Inc.
04 Feb 2021 Form 3: Novo Holdings A/S, 10% owner · Bolt Biotherapeutics, Inc.

Holds 76,903 shares of COMMON STOCK

28 Oct 2020 Form 3: Novo Holdings A/S, 10% owner · Damora Therapeutics Inc
15 Oct 2020 Form 3: Novo Holdings A/S, 10% owner · Praxis Precision Medicines, Inc.
15 Oct 2020 Form 3: Novo Holdings A/S, 10% owner · Aligos Therapeutics, Inc.
15 Oct 2020 Form 3: Novo Holdings A/S, 10% owner · Eargo, Inc.
08 Oct 2020 Form 3: Novo Holdings A/S, 10% owner · Spruce Biosciences, Inc.
18 Aug 2020 Form 3: Novo Holdings A/S, 10% owner · Harmony Biosciences Holdings, Inc.
06 Aug 2020 Form 3: Novo Holdings A/S, 10% owner · Checkmate Pharmaceuticals, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support